"Sustainable growth to come from high barrier complex generics"
by PB Jayakumar
Sep 16, 2017
1 minute
The US based global CEO of Lupin, Vinita Gupta, tells P.B. Jayakumar about the crises Indian drug companies are facing in the US.
Q. How will shrinking margins and wholesaler
You’re reading a preview, subscribe to read more.
Start your free 30 days